As one of the main tumor-infiltrating immune cell types, tumor-associated macrophages (TAMs) determine the efficacy of immunotherapy. However, limited knowledge about their phenotypically and functionally heterogeneous nature restricts their application in tumor immunotherapy. In this study, we identified a subpopulation of CD146 TAMs that exerted antitumor activity in both human samples and animal models. CD146 expression in TAMs was negatively controlled by STAT3 signaling. Reducing this population of TAMs promoted tumor development by facilitating myeloid-derived suppressor cell recruitment via activation of JNK signaling. Interestingly, CD146 was involved in the NLRP3 inflammasome-mediated activation of macrophages in the tumor microenvironment, partially by inhibiting transmembrane protein 176B (TMEM176B), an immunoregulatory cation channel. Treatment with a TMEM176B inhibitor enhanced the antitumor activity of CD146 TAMs. These data reveal a crucial antitumor role of CD146 TAMs and highlight the promising immunotherapeutic approach of inhibiting CD146 and TMEM176B.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10387481PMC
http://dx.doi.org/10.1038/s41423-023-01047-4DOI Listing

Publication Analysis

Top Keywords

cd146 tams
12
subpopulation cd146
8
antitumor activity
8
tams
6
cd146
6
cd146 macrophages
4
macrophages enhances
4
antitumor
4
enhances antitumor
4
antitumor immunity
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!